{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:55:24Z","timestamp":1761512124005},"reference-count":18,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.vaccine.2005.06.017","type":"journal-article","created":{"date-parts":[[2005,7,12]],"date-time":"2005-07-12T16:06:18Z","timestamp":1121184378000},"page":"5144-5148","source":"Crossref","is-referenced-by-count":10,"title":["Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up"],"prefix":"10.1016","volume":"23","author":[{"given":"Ron","family":"Dagan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7oise","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2005.06.017_bib1","first-page":"333","article-title":"Hepatitis A and B vaccines in children","volume":"11","author":"Lieberman","year":"1996","journal-title":"Adv Pediatr Infect Dis"},{"key":"10.1016\/j.vaccine.2005.06.017_bib2","first-page":"270","article-title":"Significance of hepatitis in children in day care","volume":"1","author":"Shapiro","year":"1990","journal-title":"Semin in Pediatr Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2005.06.017_bib3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/jmv.1890460321","article-title":"Immunogenicity and safety of a new inactivated hepatitis A vaccine in a comparative study","volume":"46","author":"Goilav","year":"1995","journal-title":"J Med Virol"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2005.06.017_bib4","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1099\/0022-1317-68-9-2487","article-title":"Properties of a hepatitis A virus candidate vaccine strain","volume":"68","author":"Heinricy","year":"1987","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2005.06.017_bib5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF01713047","article-title":"Clinical development of anew inactivated hepatitis A vaccine","volume":"24","author":"Vidor","year":"1996","journal-title":"Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2005.06.017_bib6","first-page":"116","article-title":"Comparison of the safety and immunogenicity of two inactivated hepatitis A vaccines","volume":"14","author":"Zuckerman","year":"1997","journal-title":"Advances Therapy"},{"key":"10.1016\/j.vaccine.2005.06.017_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/tropej\/49.6.333","article-title":"Immunogenicity and safety of two doses of a paediatric hepatitis a vaccine in thai children: comparison of three vaccination schedules","volume":"49","author":"Lolekha","year":"2003","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.vaccine.2005.06.017_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00006454-200101000-00009","article-title":"Safety and immunogenicity of a pediatric formulation of inactivated hepatitis A vaccine in Argentinean children","volume":"20","author":"Lopez","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2005.06.017_bib9","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0264-410X(98)00461-7","article-title":"Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine","volume":"17","author":"Dagan","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2005.06.017_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jmv.1890010303","article-title":"Serological investigation of patients and family contacts in an epidemic of hepatitis A","volume":"1","author":"Frosner","year":"1977","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2005.06.017_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/jmv.1890410306","article-title":"Sensitive assays for hepatitis A antibodies","volume":"41","author":"Miller","year":"1993","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2005.06.017_bib12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s10096-003-1094-0","article-title":"Aventis Pasteur vaccines containing inactivated hepatitis A virus: a compilation of immunogenicity data","volume":"23","author":"Vidor","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2005.06.017_bib13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMcp031540","article-title":"Prevention of hepatitis A with the hepatitis A vaccine","volume":"350","author":"Craig","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2005.06.017_bib14","unstructured":"Dagan R, Leventhal A, Anis E, Slater P, Shouval D. National hepatitis a virus (HAV) immunization program aimed exclusively at toddlers in an endemic country resulting in >90% reduction in morbidity rate in all ages [Abstract # 825], 40th Annual Meeting of the Infectious Diseases Society of America, 24\u201327 October 2002, Chicago, IL."},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2005.06.017_bib15","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/S0168-8278(05)80371-X","article-title":"Worldwide epidemiology of hepatitis A virus infection","volume":"18","author":"Shapiro","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2005.06.017_bib16","unstructured":"Centers for Disease Control and Prevention, CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999; 48 (no. RR-12)."},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2005.06.017_bib17","first-page":"S228","article-title":"Cost\/benefit analysis, universal hepatitis A vaccination in Uruguay","volume":"8","author":"Montano","year":"2004","journal-title":"Int J Infect Diseases"},{"issue":"10","key":"10.1016\/j.vaccine.2005.06.017_bib18","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/01.inf.0000091295.53969.6a","article-title":"Regional variation in the cost effectiveness of childhood hepatitis A immunization","volume":"22","author":"Jacobs","year":"2003","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0500616X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0500616X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T10:53:29Z","timestamp":1548327209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0500616X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":18,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0264410X0500616X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2005.06.017","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}